Courtney Midanek is a leader in Kaufman Hall’s Mergers and Acquisitions practice, with more than 20 years of experience in capital markets, valuations, and M&A. She provides partnership advisory services for a variety of healthcare clients in both acute and non-acute care.

Prior to Kaufman Hall, Courtney was in the Business Expansion Group of the Blue Cross and Blue Shield Association (BCBSA), where she supported strategic asset and partnership initiatives for BCBSA and the BCBS Plans. She previously held various roles at BMO Capital Markets, with a focus on M&A in the Corporate Development Group. Courtney began her career as an industry generalist in the M&A advisory group of Robert W. Baird & Co.  

She holds an M.B.A. from Northwestern University, with concentrations in Finance, Management, and Strategy.

All Specialties:

Mergers & Acquisitions
Joint Ventures & Partnerships
Laboratory Services
Hospice & Home Health

Insights from Courtney Midanek

laboratory-services_flash-report-august_2018
laboratory-services_flash-report-august_2018

Industry Flash Report: Laboratory Services August 2018

Hospital-based and independent labs are increasingly challenged by depressed volume, declining payment rates, and market disruptions. Projected losses for public lab companies were offset in Q1 2018 by increased M&A activity, strong results across core lab products and services, and a severe flu...
Research Report
multimedia-video-graphic
multimedia-video-graphic

What's Your Lab Strategy?

Until recently, many hospital and health systems have counted on relatively stable margins from outreach laboratory departments. However, the economics of lab testing are changing dramatically due to depressed volume, declining payment rates, and accelerated consolidation. These challenges are...
Webinar
whats_your_lab_strategy-_the_economics_are_changing_dramatically
whats_your_lab_strategy-_the_economics_are_changing_dramatically

What’s Your Lab Strategy? The Economics Are Changing Dramatically

Until recently, many hospital and health system executives have counted on relatively stable margins from laboratory departments. The economics of lab testing is changing dramatically due to market forces, including reduced Medicare payments, competition from national labs, higher cost sharing for...
Article